Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

US Patent 9896445 · Granted Feb 20, 2018

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →